169 related articles for article (PubMed ID: 11477172)
1. Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients.
Espinosa M; Martin-Malo A; Alvarez de Lara MA; Aljama P
Nephrol Dial Transplant; 2001 Aug; 16(8):1669-74. PubMed ID: 11477172
[TBL] [Abstract][Full Text] [Related]
2. [Natural history of HCV infection and risk of death in a cohort of patients on long-term hemodialysis].
Dattolo P; Lombardi M; Ferro G; Michelassi S; Cerrai T; Pizzarelli F
G Ital Nefrol; 2006; 23(6):585-90. PubMed ID: 17173265
[TBL] [Abstract][Full Text] [Related]
3. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group.
Pereira BJ; Natov SN; Bouthot BA; Murthy BV; Ruthazer R; Schmid CH; Levey AS
Kidney Int; 1998 May; 53(5):1374-81. PubMed ID: 9573555
[TBL] [Abstract][Full Text] [Related]
4. Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients.
Mitwalli AH; Alam A; Al-Wakeel J; Al Suwaida K; Tarif N; Schaar TA; Al Adbha B; Hammad D
Nephron Clin Pract; 2006; 102(2):c72-80. PubMed ID: 16244496
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus infection in haemodialysis: the 'no-isolation' policy should not be generalized.
Agarwal SK; Dash SC; Gupta S; Pandey RM
Nephron Clin Pract; 2009; 111(2):c133-40. PubMed ID: 19147995
[TBL] [Abstract][Full Text] [Related]
6. Risk of death among chronic dialysis patients infected with hepatitis C virus.
Stehman-Breen CO; Emerson S; Gretch D; Johnson RJ
Am J Kidney Dis; 1998 Oct; 32(4):629-34. PubMed ID: 9774125
[TBL] [Abstract][Full Text] [Related]
7. HCV-RNA Pcr Positivity In Hcv Antibody Negative Patients Undergoing Haemodialysis.
Kiani IG; Khan AN; Butt B; Sabir S; Ejaz S; Perveen A; Ghani E
J Ayub Med Coll Abbottabad; 2018; 30(3):397-400. PubMed ID: 30465373
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection during haemodialysis in India.
Agarwal SK; Dash SC; Irshad M
J Assoc Physicians India; 1999 Dec; 47(12):1139-43. PubMed ID: 11225211
[TBL] [Abstract][Full Text] [Related]
9. Liver disease in dialysis patients with antibodies to hepatitis C virus.
al-Wakeel J; Malik GH; al-Mohaya S; Mitwalli A; Baroudi F; el Gamal H; Kechrid M
Nephrol Dial Transplant; 1996 Nov; 11(11):2265-8. PubMed ID: 8941588
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of hepatitis C infection after liver transplantation.
Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
[TBL] [Abstract][Full Text] [Related]
11. Impact of hepatitis C virus infection on renal transplant outcome in India--a single centre study.
Agarwal SK; Dash SC; Irshad M; Gupta S; Bhowmik D; Tiwari SC; Guleria S; Mehta SN
J Assoc Physicians India; 2000 Dec; 48(12):1155-9. PubMed ID: 11280219
[TBL] [Abstract][Full Text] [Related]
12. Effect of hepatitis C virus infection and abstinence from alcohol on survival in patients with alcoholic cirrhosis.
Serra MA; Escudero A; Rodríguez F; del Olmo JA; Rodrigo JM
J Clin Gastroenterol; 2003 Feb; 36(2):170-4. PubMed ID: 12544203
[TBL] [Abstract][Full Text] [Related]
13. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region.
Di Napoli A; Pezzotti P; Di Lallo D; Petrosillo N; Trivelloni C; Di Giulio S;
Am J Kidney Dis; 2006 Oct; 48(4):629-37. PubMed ID: 16997059
[TBL] [Abstract][Full Text] [Related]
15. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
16. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
[TBL] [Abstract][Full Text] [Related]
17. Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension.
Di Marco V; Calvaruso V; Ferraro D; Bavetta MG; Cabibbo G; Conte E; Cammà C; Grimaudo S; Pipitone RM; Simone F; Peralta S; Arini A; Craxì A
Gastroenterology; 2016 Jul; 151(1):130-139.e2. PubMed ID: 27039970
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit.
Forns X; Fernández-Llama P; Pons M; Costa J; Ampurdanés S; López-Labrador FX; Olmedo E; López-Pedret J; Darnell A; Revert L; Sánchez-Tapias JM; Rodés J
Nephrol Dial Transplant; 1997 Apr; 12(4):736-40. PubMed ID: 9141004
[TBL] [Abstract][Full Text] [Related]
19. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies.
Fabrizi F; Takkouche B; Lunghi G; Dixit V; Messa P; Martin P
J Viral Hepat; 2007 Oct; 14(10):697-703. PubMed ID: 17875004
[TBL] [Abstract][Full Text] [Related]
20. Pretransplant hepatitis C virus infection: a predictor of proteinuria after renal transplantation.
Hestin D; Guillemin F; Castin N; Le Faou A; Champigneulles J; Kessler M
Transplantation; 1998 Mar; 65(5):741-4. PubMed ID: 9521213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
